Dr. Anastassia Kanavarioti is the Founder and Director
of Yenos Analytical LLC, a biotechnology company, located in El Dorado Hills,
California, USA. She founded Yenos Analytical in 2013, doing contract work for
biotechnology companies across the USA, and original research on nanopore-based
quantification of nucleic acid traces in biofluids. During 2002-2012, she
worked for pharmaceutical and biotechnology companies in the Bay area, and
during 1988 to 2001 worked as a Research Professor at the Chemistry and
Biochemistry Department of the University of California in Santa Cruz (UCSC).
During her tenure at UCSC, she received continuous NASA grant support for
research in the field of Astrobiology and the Origin of Life. Her publications
in that field are still cited by a Nobel Prize winner (Professor Jack Szostak)
and his coworkers who are working currently in this area. Her expertise in
developing analytical methods for RNA purity evaluation is evidenced by her
2019 article showing over 48 thousand accesses and 57 citations. Her third and
current area of interest is in nanopores used as sensing analytical
instruments, funded by NIH with three Phase I SBIR grants. She holds a BS in
Chemistry from Athens University in Greece (1974) and a Ph.D. in Organic
Chemistry from UCSC (1981). Dr. Kanavarioti has authored over 60 peer-reviewed
publications and was recently awarded three US patents on a novel nanopore-based
blood/urine test for multiple-cancer early detection (MCED).
